Compare Novo Nordisk A/S (NVO) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Select Medical Holdings Corporation — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Novo Nordisk A/S is far larger — about 107.6× Select Medical Holdings Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | SEM | |
|---|---|---|
Market Cap | $220.53B | $2.05B |
Sector | Health | Health |
52-Week High | $71.70 | $16.66 |
52-Week Low | $35.29 | $11.77 |
Enterprise Value | $239.49B | $5.01B |
Dividend Yield | 3.63% | 1.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
